News & Media
News & Media

News & Media

Follow us on our journey as we harness the power of radiopharmaceutical technology to take on cancer’s toughest tumors. This journey has brought us to a new name: We are now Mariana Oncology

Check back here for the latest on Mariana Oncology.

Mariana Oncology Recognized as a 2022 Prix Galien USA Nominee for Prix Galien Startup

CAMBRIDGE, Mass., August 17, 2022 – Mariana Oncology, Inc. (“Mariana Oncology”), a biotechnology company focused on developing innovative radiopharmaceutical therapies for oncological diseases, today announced that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, named Mariana Oncology a 2022 Prix Galien USA Award nominee for “Prix Galien Startup.” Winners…

Mariana Oncology Appoints Georgette Verdin as Chief People Officer
Mariana Oncology Appoints Karen Smith, M.D., Ph.D., as Independent Board Director
Mariana Oncology Expands Radiopharmaceutical Expertise with Appointment of Bernard Lambert, Ph.D. as Chief Technology Officer
Mariana Oncology Appoints Kapil Dhingra, MBBS, to Board of Directors
Mariana Oncology Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals

Contact Us

Mariana Oncology
2F Gill Street
Woburn MA 01801

For Media:

For Investors: